207 related articles for article (PubMed ID: 27032878)
1. Editorial foreword special issue: "Angiogenesis-convergent or divergent, that is the question: Research toward targeted strategies in oncology".
Cai J
Cancer Lett; 2016 Oct; 380(2):523-524. PubMed ID: 27032878
[No Abstract] [Full Text] [Related]
2. Classical and non-classical proangiogenic factors as a target of antiangiogenic therapy in tumor microenvironment.
Marech I; Leporini C; Ammendola M; Porcelli M; Gadaleta CD; Russo E; De Sarro G; Ranieri G
Cancer Lett; 2016 Sep; 380(1):216-26. PubMed ID: 26238184
[TBL] [Abstract][Full Text] [Related]
3. Why haven't we cured cancer?
Harding E
Lancet Oncol; 2017 Jul; 18(7):861-862. PubMed ID: 28677566
[No Abstract] [Full Text] [Related]
4. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem cells and their vascular niche: Do they benefit from each other?
Ping YF; Zhang X; Bian XW
Cancer Lett; 2016 Oct; 380(2):561-567. PubMed ID: 25979233
[TBL] [Abstract][Full Text] [Related]
6. Editorial: Angiogenesis agents.
Marcinkiewicz C
Curr Pharm Des; 2007; 13(35):3543-4. PubMed ID: 18220790
[No Abstract] [Full Text] [Related]
7. Bone morphogenetic proteins in tumour associated angiogenesis and implication in cancer therapies.
Ye L; Jiang WG
Cancer Lett; 2016 Oct; 380(2):586-597. PubMed ID: 26639195
[TBL] [Abstract][Full Text] [Related]
8. Molecular regulation of tumor angiogenesis and perfusion via redox signaling.
Miller TW; Isenberg JS; Roberts DD
Chem Rev; 2009 Jul; 109(7):3099-124. PubMed ID: 19374334
[No Abstract] [Full Text] [Related]
9. Pathophysiology of tumor neovascularization.
Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ishikura H
Vasc Health Risk Manag; 2005; 1(4):277-90. PubMed ID: 17315600
[TBL] [Abstract][Full Text] [Related]
10. The heterogeneity of cancer endothelium: The relevance of angiogenesis and endothelial progenitor cells in cancer microenvironment.
Armani G; Pozzi E; Pagani A; Porta C; Rizzo M; Cicognini D; Rovati B; Moccia F; Pedrazzoli P; Ferraris E
Microvasc Res; 2021 Nov; 138():104189. PubMed ID: 34062191
[TBL] [Abstract][Full Text] [Related]
11. The potential role of angiogenic factors in rheumatoid arthritis.
Azizi G; Boghozian R; Mirshafiey A
Int J Rheum Dis; 2014 May; 17(4):369-83. PubMed ID: 24467605
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel drug targets for angiostatic cancer therapy; it takes two to tango.
Thijssen VL; van Beijnum JR; Mayo KH; Griffioen AW
Curr Pharm Des; 2007; 13(35):3576-83. PubMed ID: 18220794
[TBL] [Abstract][Full Text] [Related]
13. Overview of pre-clinical and clinical studies targeting angiogenesis in pancreatic ductal adenocarcinoma.
Craven KE; Gore J; Korc M
Cancer Lett; 2016 Oct; 381(1):201-10. PubMed ID: 26723874
[TBL] [Abstract][Full Text] [Related]
14. The ubiquitin-proteasome system meets angiogenesis.
Rahimi N
Mol Cancer Ther; 2012 Mar; 11(3):538-48. PubMed ID: 22357635
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of angiogenesis in cancers.
Pang RW; Poon RT
Vasc Health Risk Manag; 2006; 2(2):97-108. PubMed ID: 17319453
[TBL] [Abstract][Full Text] [Related]
16. The Sabotaging Role of Myeloid Cells in Anti-Angiogenic Therapy: Coordination of Angiogenesis and Immune Suppression by Hypoxia.
Li C; Liu T; Bazhin AV; Yang Y
J Cell Physiol; 2017 Sep; 232(9):2312-2322. PubMed ID: 27935039
[TBL] [Abstract][Full Text] [Related]
17. Catecholamines regulate tumor angiogenesis.
Chakroborty D; Sarkar C; Basu B; Dasgupta PS; Basu S
Cancer Res; 2009 May; 69(9):3727-30. PubMed ID: 19383906
[TBL] [Abstract][Full Text] [Related]
18. Redundant angiogenic signaling and tumor drug resistance.
Gacche RN; Assaraf YG
Drug Resist Updat; 2018 Jan; 36():47-76. PubMed ID: 29499837
[TBL] [Abstract][Full Text] [Related]
19. Melatonin as an angiogenesis inhibitor to combat cancer: Mechanistic evidence.
Goradel NH; Asghari MH; Moloudizargari M; Negahdari B; Haghi-Aminjan H; Abdollahi M
Toxicol Appl Pharmacol; 2017 Nov; 335():56-63. PubMed ID: 28974455
[TBL] [Abstract][Full Text] [Related]
20. Targeting the angiopoietin/Tie2 pathway: cutting tumor vessels with a double-edged sword?
Cascone T; Heymach JV
J Clin Oncol; 2012 Feb; 30(4):441-4. PubMed ID: 22184396
[No Abstract] [Full Text] [Related]
[Next] [New Search]
